2.965USD+1.54%Mkt Cap: 191.58M USDP/E: —Last update: 2026-06-01
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR m…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap191.58M USD
Enterprise Value122.73M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-22.40M USD
Revenue/Share—
Last Price2.965 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.08
PEG—
EV/EBITDA-6.06
EV/Revenue—
P/S—
P/B3.08
EPS (TTM)-0.21
EPS (Forward)-0.26
52W Range
0.270095% of range3.100
52W High3.100 USD
52W Low0.2700 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-78.32%
ROA-70.24%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.75M USD
CapEx (TTM)48.00K USD
FCF Margin—
FCF Yield-6.55%
Net Debt-60.63M USD
Net Debt/EBITDA2.99
Balance Sheet
Debt/Equity0.03
Current Ratio18.62
Quick Ratio18.33
Book Value/Sh0.9410 USD
Cash/Share0.9700 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)7.125 USD
Target Range4.000 USD – 12.00 USD
# Analysts8
Ownership
Shares Out.63.23M
Float31.50M
Insiders16.41%
Institutions64.23%
Short Interest
Short Ratio9.2d
Short % Float5.26%
Short % Out.4.54%
Shares Short2.87M
Short (prev mo.)2.76M
Technical
SMA 502.090 (+41.9%)
SMA 2001.589 (+86.6%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)391.33K
Avg Vol (10d)572.13K
Technical Indicators
RSI (14)68.4
MACD0.1580
MACD Signal0.0791
MACD Hist.+0.0789
BB Upper2.856 USD
BB Middle2.259 USD
BB Lower1.661 USD
BB Width52.91%
ATR (14)0.2593 USD
Vol Ratio (20d)1.87x